Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The company is headquartered in Hackensack, New Jersey and currently employs 213 full-time employees. The firm is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions. This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. The company also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.
Follow-Up Questions
Champions Oncology Inc (CSBR)의 PER은 얼마입니까?
Champions Oncology Inc의 PER은 19.8276입니다
Champions Oncology Inc의 CEO는 누구입니까?
Dr. Ronnie Morris은 2010부터 회사에 합류한 Champions Oncology Inc의 Chief Executive Officer입니다.
CSBR 주식의 가격 성능은 어떻습니까?
CSBR의 현재 가격은 6.69이며, 전 거래일에 decreased 0.06% 하였습니다.
Champions Oncology Inc의 주요 사업 주제나 업종은 무엇입니까?
Champions Oncology Inc은 Life Sciences Tools & Services 업종에 속하며, 해당 부문은 Health Care입니다
Champions Oncology Inc의 시가총액은 얼마입니까?
Champions Oncology Inc의 현재 시가총액은 $92.3입니다
Champions Oncology Inc는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 3명의 분석가가 Champions Oncology Inc에 대한 분석 평가를 실시했으며, 이는 2명의 강력한 매수, 4명의 매수, 1명의 보유, 0명의 매도, 그리고 2명의 강력한 매도를 포함합니다